Lifecore Biomedical to Participate in 2025 BIO CEO & Investor Conference

Rhea-AI Summary

Lifecore Biomedical (NASDAQ: LFCR), a fully integrated contract development and manufacturing organization (CDMO), has announced its participation in the 2025 BIO CEO & Investor Conference. The event will be held on February 10-11, 2025, in New York, NY.

The company's management team, including Paul Josephs, chief executive officer, and Ryan Lake, chief financial officer, will engage in one-on-one meetings during the conference. This participation demonstrates Lifecore's commitment to investor relations and market engagement.

News Market Reaction – LFCR

-3.70%

1 alert

-3.70% News Effect

On the day this news was published, LFCR declined 3.70%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

CHASKA, Minn., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at the 2025 BIO CEO & Investor Conference. The conference will take place February 10-11, 2025, in New York, NY.

Details regarding Lifecore’s participation are as follows:

• 2025 BIO CEO & Investor Conference
  Details: Lifecore management, including Paul Josephs, chief executive officer, and Ryan Lake, chief financial officer, will participate in 1-on-1 meetings
  Conference Dates: February 10-11, 2025
  Location: New York, NY

About Lifecore Biomedical

Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.

FAQ

When is Lifecore Biomedical (LFCR) participating in the 2025 BIO CEO & Investor Conference?

Lifecore Biomedical will participate in the 2025 BIO CEO & Investor Conference on February 10-11, 2025, in New York, NY.

Who will represent Lifecore Biomedical (LFCR) at the 2025 BIO CEO & Investor Conference?

Lifecore Biomedical will be represented by CEO Paul Josephs and CFO Ryan Lake at the conference.

What type of meetings will Lifecore Biomedical (LFCR) conduct at the 2025 BIO CEO Conference?

Lifecore Biomedical's management will participate in one-on-one meetings during the conference.

Where will the 2025 BIO CEO & Investor Conference featuring Lifecore Biomedical (LFCR) take place?

The 2025 BIO CEO & Investor Conference will take place in New York, NY.